Skip to content

Laser therapy in chronic shoulder pain

Different doses of laser in patients with chronic shoulder pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-48sj6d
Enrollment
Unknown
Registered
2019-06-06
Start date
2019-02-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic shoulder pain

Interventions

There are 3 intervention groups, and each group will be composed of 13 participants who will perform the exercise protocol s after this will perform the photobiomodulation (FBM) with the specific dose
Device
E02.760.169.063.500.387
E02.774

Sponsors

Universidade Federal de São Paulo - UNIFESP
Lead Sponsor
Departamento de Ciências do Movimento Humano da universidade federal de São Paulo
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with shoulder pain lasting at least 6 weeks; with ages ranging from 18 to 70 years

Exclusion criteria

Exclusion criteria: Patients who have had a history of significant trauma or systemic inflammatory conditions such as rheumatoid arthritis or rheumatic polymyalgia; neurological disorders that affect cognitive behavior and pain perception; disorders in the shoulder region that make it impossible to perform the assessments or protocol proposed; previous surgical procedure; pregnancy or breastfeeding; anticoagulant therapy; diabetes mellitus; heart conditions; shoulder infections; and people with contraindications to laser therapy will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement of function and pain through the SPADI questionnaire with an increase of 18 points at the end of the study.

Secondary

MeasureTime frame
Pain improvement measured through NRS-11 with a 2-point decrease in pain intensity in the activity that causes the most pain at the end of the study

Countries

Brazil

Contacts

Public ContactCarlos Eduardo Pinfildi

Universidade Federal de São Paulo - UNIFESP

cepinfildi@hotmail.com+55(13)3229-0100

Outcome results

None listed

Source: REBEC (via WHO ICTRP)